These results indicate that HAMP and immune checkpoint genes (PDCD1, LAG3, TIGIT, and CTLA4) were coordinately upregulated in ccRCC tissues with a strong clinical impact on patient survival outcomes. The gene discussed is TIGIT; the disease is nonpapillary renal cell carcinoma.